ATE373082T1 - Pre-adipose zelllinien - Google Patents

Pre-adipose zelllinien

Info

Publication number
ATE373082T1
ATE373082T1 AT01955350T AT01955350T ATE373082T1 AT E373082 T1 ATE373082 T1 AT E373082T1 AT 01955350 T AT01955350 T AT 01955350T AT 01955350 T AT01955350 T AT 01955350T AT E373082 T1 ATE373082 T1 AT E373082T1
Authority
AT
Austria
Prior art keywords
immortalized
cell lines
cells
adipose
methods
Prior art date
Application number
AT01955350T
Other languages
English (en)
Inventor
Christian Darimont
Katherine Mace
Andrea Pfeifer
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE373082T1 publication Critical patent/ATE373082T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01955350T 2000-07-18 2001-07-13 Pre-adipose zelllinien ATE373082T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00115489 2000-07-18

Publications (1)

Publication Number Publication Date
ATE373082T1 true ATE373082T1 (de) 2007-09-15

Family

ID=8169292

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01955350T ATE373082T1 (de) 2000-07-18 2001-07-13 Pre-adipose zelllinien

Country Status (8)

Country Link
US (1) US7294509B2 (de)
EP (1) EP1303589B1 (de)
JP (1) JP2004504024A (de)
CN (1) CN100595274C (de)
AT (1) ATE373082T1 (de)
AU (1) AU2001277539A1 (de)
DE (1) DE60130464T2 (de)
WO (1) WO2002006450A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050136039A1 (en) * 2002-03-22 2005-06-23 Joslin Diabetes Center, Inc. Adipocytes and uses thereof
WO2003082006A2 (en) * 2002-03-22 2003-10-09 Joslin Diabetes Center, Inc. Methods and compositions for preventing obesity and obesity related disorders
ATE492630T1 (de) * 2002-06-18 2011-01-15 Eisai R&D Man Co Ltd Primäre kultivierte adipozyten zur gentherapie
US20090317367A1 (en) * 2007-02-21 2009-12-24 Cedars-Sinai Medical Center Methods of producing preadipocytes and increasing the proliferation of adult adipose stem/progenitor cells
CN101259266B (zh) * 2008-04-14 2010-04-14 山东大学 一种前脂肪细胞异种疫苗及其制备方法和用途
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
CN102140437A (zh) * 2011-01-07 2011-08-03 西北农林科技大学 一种猪成熟脂肪细胞快速去分化为前体脂肪细胞的培养方法
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
KR101422559B1 (ko) * 2012-03-09 2014-07-24 창원대학교 산학협력단 지방유래 줄기세포 배양액, 이의 제조방법, 및 이를 포함하는 발모촉진용 조성물
CN102876717B (zh) * 2012-10-29 2014-06-11 东北农业大学 一种建立鸡永生化前脂肪细胞的方法
EP3795678B1 (de) 2013-04-19 2023-07-12 Biorestorative Therapies, Inc. Stammzellen aus menschlichem braunen fettgewebe und verwendungen
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
MX2017007196A (es) * 2014-12-04 2017-08-28 Intervet Int Bv Fibroblastos de embrion de pollo inmortalizados.
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
JP6714932B2 (ja) 2015-12-01 2020-07-01 株式会社ＡｄｉｐｏＳｅｅｄｓ 脊椎動物の脂肪組織由来間葉系細胞株の製造方法
EP3387113A1 (de) * 2015-12-11 2018-10-17 Intervet International B.V. Unsterbliche embryonale hühnernierenepithelzellen
US11666900B2 (en) 2018-01-24 2023-06-06 Sniper (Suzhou) Life Technology Co. Motion controlling mechanism, liquid discharging nozzle, microdroplet generating device and method, liquid driving mechanism and method, microdroplet generating method, and surface processing method of liquid discharging nozzle
CN110064443B (zh) * 2018-01-24 2021-07-30 思纳福(北京)医疗科技有限公司 微液滴平铺方法
US11946100B2 (en) 2018-01-24 2024-04-02 Sniper (Suzhou) Life Technology Co., Ltd. Microdroplet container and method for manufacturing the same, method for spreading microdroplets, microdroplet-generating kit, temperature-controlling device, oil phase composition for microdroplet generating and method for treating the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830682A (en) * 1994-09-09 1998-11-03 Zymogenetics Preparation of immortalized cells
FR2733513B1 (fr) * 1995-04-25 1997-07-18 Centre Nat Rech Scient Lignees immortalisees de cellules issues du tissu adipeux humain, leur procede de preparation et leurs applications
US5827740A (en) * 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
JP5055611B2 (ja) * 1998-09-09 2012-10-24 学校法人日本大学 前駆脂肪細胞株
WO2000024866A2 (fr) * 1998-10-26 2000-05-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Lignee cellulaire multipotente du stroma medullaire humain, et ses utilisations

Also Published As

Publication number Publication date
US7294509B2 (en) 2007-11-13
US20030175957A1 (en) 2003-09-18
DE60130464T2 (de) 2008-06-12
JP2004504024A (ja) 2004-02-12
EP1303589A1 (de) 2003-04-23
WO2002006450A1 (en) 2002-01-24
DE60130464D1 (de) 2007-10-25
EP1303589B1 (de) 2007-09-12
AU2001277539A1 (en) 2002-01-30
CN1458973A (zh) 2003-11-26
CN100595274C (zh) 2010-03-24

Similar Documents

Publication Publication Date Title
DE60130464D1 (de) Pre-adipose zelllinien
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
DK1455603T3 (da) Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
DE60330781D1 (de) Anwendung von lactobacillus zur herstellung von exopolysacchariden in nahrungsmittel und pharmazeutische zusammensetzungen
MXPA03001898A (es) Materiales y metodos para el tratamiento o prevencion de obesidad.
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
EP1670450A4 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
DE69931907D1 (de) Zusammensetzungen aus hagebutten als anti-entzündliches natürliches arzneimittel zur erleichterung/verringerung von symptomen, die mit entzündungen und arthritis zusammenhängen
EP1872668A4 (de) Nährstoffzusammensetzung
ATE263571T1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
TW200719908A (en) Dermatologic use of milk proteins
Braun‐Falco Hereditary palmoplantar keratodermas
EP3003264A1 (de) Wirkstoffkombination zur behandlung von hautalterung
PT1065947E (pt) Metodo de administracao de glutamina
TR200202488T2 (tr) Titanyum içeren yüksek işlevli su ve suyu üretmek için cihaz ve yöntem
EP1623718A4 (de) Mittel zur förderung der hautkollagenproduktion
ES2168845T3 (es) Composicion cosmetica que contiene un componente activo capaz de estimular "in vivo" la produccion de interleuquina 6 (il-6) por los queratinocitos humanos.
MX2019013825A (es) Metodos para producir productos alimenticios basados en plumas.
DE602005010256D1 (de) Produkt pflanzlichen ursprungs, das proanthocyane enthält, sowie verfahren zu seiner herstellung
BRPI0417692A (pt) uso de uma composição, método de redução dos efeitos do estresse mediado psicologicamente na pele de um ser humano ou animal, composição, suplemento nutritivo, composição cosmética, e, método para identificar um composto capaz de reduzir os efeitos e método de produção de uma composição para a redução dos efeitos, do estresse mediado psicologicamente sobre a pele de um ser humano ou animal
WO2002074921A3 (en) Methods for isolating proteins expressed by dendritic cells
FR2893504B1 (fr) Procede d'obtention d'un principe actif exhausteur de la resistance mecanique cutanee, principe actif et compositions
Sachs et al. Functional and aesthetic consequences of total platysma resection
FR2799613B1 (fr) Presentation de mets destines a l'alimentation humaine consommable a la main particulierement adaptee a la restauration rapide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties